Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic or Autologous Stem Cell Transplantation in Children and Adults
Latest Information Update: 09 Jun 2022
At a glance
- Drugs Montelukast (Primary)
- Indications Bronchiolitis obliterans
- Focus Therapeutic Use
Most Recent Events
- 09 Jun 2022 New trial record
- 01 May 2022 Primary endpoint has been met. (Number of Participants With Stable or Improved Predicted Forced Expiratory Volume 1 (FEV-1) With Published Literature)
- 01 May 2022 Results published in the Transplantation and Cellular Therapy